Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Hawkins
Is Hawkins getting weaker?
Its latest SEC filing (Jul 29, 2026) showed no major changes. Its overall score is 57/100, up 1 since Oct 28, 2026.
How is Hawkins valued vs its peers?
Priced higher than most peers relative to what it earns. Valuation scores 38/100 against 1,371 basic materials peers.EBITDA yield 5.0% vs a peer median of 8.5% (weaker than 66% of peers).EBITDA yield 5.0% vs peers 8.5% (weaker than 66% of peers).
Is Hawkins growing?
At about the same pace as its peers. Growth scores 58/100 against 1,371 basic materials peers.3-year revenue growth 5.6% vs a peer median of -0.0% (stronger than 70% of peers).3-year revenue growth 5.6% vs peers -0.0% (stronger than 70% of peers).Earnings per share growth -4.7% vs a peer median of 9.4% (weaker than 63% of peers).Earnings per share growth -4.7% vs peers 9.4% (weaker than 63% of peers).
How profitable is Hawkins?
More profitable than most of its peers. Profitability scores 74/100 against 1,371 basic materials peers.Return on assets 8.0% vs a peer median of 2.5% (stronger than 84% of peers).Return on assets 8.0% vs peers 2.5% (stronger than 84% of peers).
How risky is Hawkins?
Moderate risk relative to 1,371 basic materials peers, judged on debt, liquidity and share-price swings.Current ratio 2.27× vs a peer median of 1.76× (stronger than 65% of peers).Current ratio 2.27× vs peers 1.76× (stronger than 65% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 28, 2026 · filed Jul 29, 2026 · compared with the quarter ended Mar 29, 2026
No major changes
Previous quarter
Latest quarter
Change
Revenue (12 months)
1.1B USD
1.1B USD
+2.1%
Net income (12 months)
81.5M USD
80.6M USD
−1.1%
Operating margin
11.2%
10.7%
−0.5 pts
Free cash flow (12 months)
86.1M USD
91.7M USD
+6.5%
Debt
244.0M USD
244.0M USD
0.0%
Cash
3.9M USD
8.0M USD
+103.8%
Shares outstanding
20.9M
20.9M
+0.0%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Industry: Specialty Chemicals · 32 companies
Valuations in Specialty Chemicals are above their usual range since 2016.
74% of months since 2016 were valued lower than now.
17% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values −8% and earnings +13% (medians): earnings grew faster than prices.
Median price-to-sales is −36% vs the whole market, against a usual −31%.
2016Shaded: most expensive fifth of its range2026
This is a cyclical group: after a downturn, trailing earnings and sales fall faster than prices, which can make valuations look high near a cycle's low.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on earnings, EBITDA, sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY Mar 2022
FY Mar 2023
FY Mar 2024
FY Mar 2025
FY Mar 2026
Change
Gross margin
18.9%
17.7%
21.1%
23.1%
22.6%
▼ 0.5 pts
Operating margin
9.2%
9.4%
11.3%
12.2%
11.2%
▼ 1.0 pts
Net margin
6.7%
6.4%
8.2%
8.7%
7.5%
▼ 1.1 pts
Return on assets (ROA)
9.1%
10.2%
11.5%
11.0%
8.3%
▼ 2.7 pts
Return on equity (ROE)
17.0%
17.2%
18.6%
18.3%
15.3%
▼ 3.1 pts
Free cash flow margin
1.8%
3.1%
13.0%
7.2%
7.9%
▲ 0.8 pts
Current ratio
2.24×
2.55×
1.96×
2.37×
2.21×
▼ 7.0%
Quick ratio
1.31×
1.58×
1.24×
1.51×
1.46×
▼ 3.4%
Debt to equity
0.41×
0.32×
0.24×
0.35×
0.46×
▲ 32%
HWKN price history
Price history is added with the daily price update and will appear after the next one.